GLP1R and type 2 diabetes mellitus: GLP-1 receptor agonists (GLP-1RAs), such as lixisenatide, exenatide, liraglutide, and semaglutide, have been widely utilized in the therapy of T2D due to their advantages in blood glucose control, weight loss, and protection of pancreatic β cells, etc (138, 139).